Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

crossbeta.com

Stage

Acquired | Acquired

Valuation

$0000 

About Crossbeta Biosciences

Crossbeta is a privately held company based in the Netherlands with a proprietary technology for efficient oligomer-based drug discovery, with applications in Alzheimer's, Parkinson's, ALS and Huntington's disease. Crossbeta's technology allows the generation of well-defined stable, pathobiologically functional, oligomers. Crossbeta's oligomers allow fast, de-risked drug candidate screening and the generation of antibodies with high affinity as well as high specificity. The capabilities of Crossbeta's technology have already yielded multiple antibodies with biomarker/diagnostic and therapeutic potential for Alzheimer's and Parkinson's disease.

Crossbeta Biosciences Headquarters Location

Yalelaan 62

Utrecht, 3584 CM,

Netherlands

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Crossbeta Biosciences Patents

Crossbeta Biosciences has filed 5 patents.

The 3 most popular patent topics include:

  • Alzheimer's disease
  • Clusters of differentiation
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/7/2017

8/31/2021

Monoclonal antibodies, Alzheimer's disease, Clusters of differentiation, Psychiatric diagnosis, Immunology

Grant

Application Date

11/7/2017

Grant Date

8/31/2021

Title

Related Topics

Monoclonal antibodies, Alzheimer's disease, Clusters of differentiation, Psychiatric diagnosis, Immunology

Status

Grant

Latest Crossbeta Biosciences News

Crossbeta Biosciences BV Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250

Oct 6, 2018

10:54 EDT 6 Oct 2018 | BioPortfolio Reports Summary Crossbeta Biosciences BV Crossbeta is a biotech company that offers drug discovery programs for the treatment of misfolded protein diseases. The company develops drugs against Alzheimer's, Parkinson's, Huntington's disease and ALS. It offers screening of oligomerspecific therapeutics and for the development of biomarker and diagnostic assays. Crossbeta's technology is used to identify compounds that target and detoxify the toxic aggregates. The company's therapeutic expertise spans metabolic diseases which include diabetes type 2 and central nervous system disorders. It operates through partnerships with drug development and bioscience companies. Crossbeta is headquartered in Utrecht, the Netherlands. Crossbeta Biosciences BV Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

  • Where is Crossbeta Biosciences's headquarters?

    Crossbeta Biosciences's headquarters is located at Yalelaan 62, Utrecht.

  • What is Crossbeta Biosciences's latest funding round?

    Crossbeta Biosciences's latest funding round is Acquired.

  • Who are the investors of Crossbeta Biosciences?

    Investors of Crossbeta Biosciences include ImmunoPrecise Antibodies.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.